Literature DB >> 2829209

Lipid composition and fluidity of the human immunodeficiency virus.

R C Aloia1, F C Jensen, C C Curtain, P W Mobley, L M Gordon.   

Abstract

Lipid analyses of the human immunodeficiency virus (HIV) propagated in Hut 78 cells indicated a low total lipid/protein ratio, a high cholesterol/phospholipid molar ratio, and major phospholipids consisting of phosphatidylcholine, phosphatidylethanolamine, sphingomyelin, and phosphatidylserine; comparable lipid profiles were noted for human erythrocytes and other RNA viruses. Electron spin resonance (ESR) studies of HIV labeled with 5-nitroxide stearate (N-oxy-4',4'-dimethyloxazolidine derivative of ketostearate) showed a low "fluidity" at 37 degrees C, similar to other enveloped RNA viruses and erythrocytes and probably due to the high cholesterol/phospholipid ratio. Ethanol (50%) completely disrupts the envelope, contributing to the rapid inactivation of HIV by ethanol. Contrarily, heating to 57 degrees C causes much less fluidization, and this heating may play a role in the slower viral inactivation at high temperatures. Should a critical minimum ordering in the HIV envelope be necessary for viral stability and infectivity, manipulating the lipid composition or fluidizing the HIV membrane, or both, may provide an untried therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829209      PMCID: PMC279664          DOI: 10.1073/pnas.85.3.900

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The effect of the antioxidant butylated hydroxy toluene on serum lipid and glycoprotein levels in the rat.

Authors:  A J DAY; A R JOHNSON; M W O'HALLORAN; C J SCHWARTZ
Journal:  Aust J Exp Biol Med Sci       Date:  1959-06

2.  Butylated hydroxytoluene protects chickens exposed to Newcastle disease virus.

Authors:  M Brugh
Journal:  Science       Date:  1977-09-23       Impact factor: 47.728

3.  Studies on spin-labelled egg lecithin dispersions.

Authors:  L M Gordon; R D Sauerheber
Journal:  Biochim Biophys Acta       Date:  1977-04-01

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Lipid organization of the membrane of vesicular stomatitis virus.

Authors:  E J Patzer; N F Moore; Y Barenholz; J M Shaw; R R Wagner
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

6.  Perturbations of the dynamics of lipid alkyl chains in membrane systems: effect on the activity of membrane-bound enzymes.

Authors:  S Eletr; M A Williams; T Watkins; A D Keith
Journal:  Biochim Biophys Acta       Date:  1974-03-15

7.  Precise quantitative determination of human blood lipids by thin-layer and triethylaminoethylcellulose column chromatography. I. Erythrocyte lipids.

Authors:  J D Turner; G Rouser
Journal:  Anal Biochem       Date:  1970-12       Impact factor: 3.365

8.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

9.  Effect of membrane protein on lipid bilayer structure: a spin-label electron spin resonance study of vesicular stomatitis virus.

Authors:  F R Landsberger; R W Compans
Journal:  Biochemistry       Date:  1976-06-01       Impact factor: 3.162

10.  Spin-label studies on rat liver and heart plasma membranes: do probe-probe interactions interfere with the measurement of membrane properties?

Authors:  R D Sauerheber; L M Gordon; R D Crosland; M D Kuwahara
Journal:  J Membr Biol       Date:  1977-02-24       Impact factor: 1.843

View more
  58 in total

1.  Nuclear transport of oligonucleotides in HepG2-cells mediated by protamine sulfate and negatively charged liposomes.

Authors:  C Welz; W Neuhuber; H Schreier; M Metzler; R Repp; W Rascher; A Fahr
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.

Authors:  I Rousso; M B Mixon; B K Chen; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Quantitative experimental assessment of macromolecular crowding effects at membrane surfaces.

Authors:  Rania Leventis; John R Silvius
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

Review 4.  HIV-1 assembly, budding, and maturation.

Authors:  Wesley I Sundquist; Hans-Georg Kräusslich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 5.  Sterol-rich plasma membrane domains in fungi.

Authors:  Francisco J Alvarez; Lois M Douglas; James B Konopka
Journal:  Eukaryot Cell       Date:  2007-03-16

Review 6.  The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Authors:  Marinieve Montero; Nienke E van Houten; Xin Wang; Jamie K Scott
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

7.  Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.

Authors:  Paolo Ingallinella; Elisabetta Bianchi; Neal A Ladwa; Ying-Jie Wang; Renee Hrin; Maria Veneziano; Fabio Bonelli; Thomas J Ketas; John P Moore; Michael D Miller; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

8.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

9.  Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions.

Authors:  Erin M Scherer; Daniel P Leaman; Michael B Zwick; Andrew J McMichael; Dennis R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 10.  Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.

Authors:  Hyun A Yi; Brian C Fochtman; Robert C Rizzo; Amy Jacobs
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.